Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$32.28 - $44.3 $297,169 - $407,825
-9,206 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$31.45 - $40.54 $888,902 - $1.15 Million
-28,264 Reduced 75.43%
9,206 $306,000
Q3 2020

Nov 13, 2020

BUY
$26.0 - $34.5 $974,220 - $1.29 Million
37,470 New
37,470 $1.2 Million
Q2 2020

Aug 14, 2020

SELL
$14.11 - $29.42 $587,244 - $1.22 Million
-41,619 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$13.63 - $33.98 $567,266 - $1.41 Million
41,619 New
41,619 $667,000
Q2 2019

Aug 14, 2019

SELL
$23.0 - $32.19 $333,500 - $466,754
-14,500 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$13.91 - $31.15 $201,695 - $451,675
14,500 New
14,500 $421,000
Q3 2018

Nov 14, 2018

SELL
$18.95 - $28.08 $352,470 - $522,287
-18,600 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$20.0 - $29.72 $372,000 - $552,792
18,600 New
18,600 $439,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.8B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Quantitative Investment Management, LLC Portfolio

Follow Quantitative Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Investment Management, LLC with notifications on news.